Memo Therapeutics raised €14M in a Series A round in Nov 2020. The company is based in Zurich, Switzerland. Investors in the round: Redalpine. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €14M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
